Low-dose thalidomide in patients with metastatic renal cell carcinoma.
about
Effect of thalidomide in combination with gemcitabine on human pancreatic carcinoma SW-1990 cell lines in vitro and in vivo.Vascular endothelial growth receptor 1 acts as a stress-associated protein in the therapeutic response to thalidomide.Thalidomide inhibits proliferation and epithelial-mesenchymal transition by modulating CD133 expression in pancreatic cancer cells.
P2860
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@ast
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@en
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@nl
type
label
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@ast
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@en
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@nl
prefLabel
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@ast
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@en
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@nl
P2093
P1476
Low-dose thalidomide in patients with metastatic renal cell carcinoma.
@en
P2093
Abdul Qayyum
Altaf Hashmi
Mutahir Ali Tunio
Najeeb Naimatullah
Rehan Masood
P304
P577
2012-09-01T00:00:00Z